ArticleTherapeutic advances in hematology2019

A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting.

Robert M Rifkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.